• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 105 Show All Page 1 of 3
GRN No.
(sorted A-Z)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  114
Pectate lyase enzyme preparation from Bacillus subtilis Jan 27, 2003 FDA has no questions
  140
Crystalline lutein Jun 14, 2004 FDA has no questions; some uses may require a color additive listing Jul 29, 2016
  208
Erythritol Jan 25, 2007 FDA has no questions
  214
Asparaginase enzyme preparation from Aspergillus niger expressing the asparaginase gene from A. niger Mar 12, 2007 FDA has no questions Feb 8, 2017
May 2, 2016
  261
Oat hull fiber Feb 3, 2009 FDA has no questions Oct 14, 2016
  367
Purified steviol glycosides with rebaudioside A and stevioside as the principal components Jul 8, 2011 FDA has no questions Dec 7, 2016
  559
Bacillus coagulans Apr 2, 2015 At the notifier's request, FDA ceased to evaluate this notice
  560
Bacillus licheniformis Apr 2, 2015 At the notifier's request, FDA ceased to evaluate this notice
  561
Bacillus pumilus Apr 2, 2015 At the notifier's request, FDA ceased to evaluate this notice
  562
Bacillus subtilis Apr 2, 2015 At the notifier's request, FDA ceased to evaluate this notice
  576
Oligofructose and inulin Dec 9, 2015 FDA has no questions
  581
Un-hydrolyzed and hydrolyzed pea protein Jan 25, 2016 FDA has no questions
  582
Inulin from Agave tequilana Nov 25, 2015 At the notifier's request, FDA ceased to evaluate this notice
  687
  583
Esterified propoxylated glycerol Nov 12, 2015 FDA has no questions
  584
Cellulase from Penicillium funiculosum Sep 30, 2015 FDA has no questions
  585
1-methylcyclopropene complex Jan 29, 2016 FDA has no questions
  586
Taurine Dec 9, 2015 FDA has no questions
  587
Acetolactate decarboxylase from Bacillus brevis produced in Bacillus licheniformis Sep 8, 2015 FDA has no questions
  588
Zeaxanthin from Capsicum annum (paprika) Feb 29, 2016 FDA has no questions; some uses may require a color additive listing
  589
Xylanase from Aspergillus niger Sep 17, 2015 FDA has no questions
  590
Pyrroloquinoline quinone Jan 18, 2016 At the notifier's request, FDA ceased to evaluate this notice
  625
  591
Streptococcus salivarius K12 Jan 25, 2016 FDA has no questions (in PDF) (340 kB)
  592
β-glucanase from Bacillus subtilis Oct 7, 2015 FDA has no questions
  593
Colicin preparations Dec 18, 2015 FDA has no questions
  594
α-amylase from Geobacillus stearothermophilus produced in Bacillus licheniformis Dec 18, 2015 FDA has no questions
  595
gamma-aminobutyric acid Nov 10, 2015 At the notifier's request, FDA ceased to evaluate this notice
  596
Breadfruit flour Feb 21, 2016 FDA has no questions
  597
Bacillus coagulans SNZ1969 spore preparation Feb 29, 2016 FDA has no questions
  598
Thermolysin enzyme preparation derived from Geobacillus stearothermophilus Feb 29, 2016 FDA has no questions
  599
Citrus fiber Feb 17, 2016 FDA has no questions
  600
Hydroxytyrosol May 13, 2016 FDA has no questions
  601
Preparation of Bacillus coagulans strain MTCC 5856 spores Apr 28, 2016 FDA has no questions
  602
N-acetyl-D-neuraminic acid Feb 1, 2016 FDA has no questions
  603
Preparation containing the bacterial monophages, BP-63 and BP-12, specific to Salmonella Jul 28, 2016 FDA has no questions
  604
Baker's Yeast (Saccharomyces cerevisiae) expressing asparaginase II Apr 27, 2016 FDA has no questions
  605
Fructo-oligosaccharides Mar 17, 2016 FDA has no questions
  606
Vinyl acetate-vinyl laurate copolymers May 27, 2016 FDA has no questions
  607
Glucosylated steviol glycosides (minimum purity 80%) Oct 14, 2016 FDA has no questions Nov 15, 2019
  608
Pea protein concentrate May 27, 2016 FDA has no questions
  610
Isomaltodextrin Jun 6, 2016 FDA has no questions Jan 17, 2024
  611
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 Apr 15, 2016 At the notifier's request, FDA ceased to evaluate this notice
  612
Fractionated whey protein isolate containing cows milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2 May 19, 2016 At the notifier's request, FDA ceased to evaluate this notice
  613
Apple peel powder Mar 8, 2016 At the notifier's request, FDA ceased to evaluate this notice
  805
  614
Chromium polynicotinate Apr 12, 2016 FDA has no questions
  615
High-amylose cornstarch Jun 24, 2016 FDA has no questions
  616
High-amylose cornstarch acetate Jun 24, 2016 FDA has no questions
  617
α-amylase from Cytophaga sp. produced in Bacillus licheniformis Apr 8, 2016 At the notifier's request, FDA ceased to evaluate this notice
  618
Purified seawater May 27, 2016 FDA has no questions
  619
Purified steviol glycosides May 27, 2016 FDA has no questions
  620
Galacto-oligosaccharides Jul 21, 2016 FDA has no questions

Show All 

jump to page of 3 


GRN No.
(sorted A-Z)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-